Barrier to autointegration factor (BAF) inhibits vaccinia virus intermediate transcription in the absence of the viral B1 kinase

Virology

Volumn 444, Issue 1-2, 2013, Pages 363-373

  Ibrahim, Nouhou ^a,b   Wicklund, April ^a   Jamin, Augusta ^a,b   Wiebe, Matthew S ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b UNIVERSITY OF NEBRASKA   (United States)

Author keywords

BAF; BANF1; Barrier to autointegration; Transcription; Vaccinia; Virus host interaction

Indexed keywords

BARRIER TO AUTOINTEGRATION FACTOR; DOUBLE STRANDED DNA; UNCLASSIFIED DRUG; VIRAL B1 KINASE; VIRUS ENZYME;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA REPLICATION; DNA SEQUENCE; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; POXVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VACCINIA VIRUS; VIRUS INHIBITION; VIRUS TRANSCRIPTION;

BAF; BANF1; BARRIER TO AUTOINTEGRATION; TRANSCRIPTION; VACCINIA; VIRUS HOST INTERACTION;

ANIMALS; CELL LINE; DNA-BINDING PROTEINS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; NUCLEAR PROTEINS; TRANSCRIPTION, GENETIC; VACCINIA VIRUS; VIRAL PROTEINS; VIRUS REPLICATION;

VACCINIA VIRUS;

EID: 84882927513     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.07.002     Document Type: Article

References (73)

1. Ahn B.Y., Gershon P.D., Jones E.V., Moss B. Identification of rpo30, a vaccinia virus RNA polymerase gene with structural similarity to a eucaryotic transcription elongation factor. Mol. Cell. Biol. 1990, 10:5433-5441.
2. Amegadzie B.Y., Ahn B.Y., Moss B. Identification, sequence, and expression of the gene encoding a Mr 35,000 subunit of the vaccinia virus DNA-dependent RNA polymerase. J. Biol. Chem. 1991, 266:13712-13718.
3. Baldick C.J., Keck J.G., Moss B. Mutational analysis of the core, spacer, and initiator regions of vaccinia virus intermediate-class promoters. J. Virol. 1992, 66:4710-4719.
4. Banham A.H., Smith G.L. Vaccinia virus gene B1R encodes a 34-kDa serine/threonine protein kinase that localizes in cytoplasmic factories and is packaged into virions. Virology 1992, 191:803-812.
5. Black E.P., Moussatche N., Condit R.C. Characterization of the interactions among vaccinia virus transcription factors G2R, A18R, and H5R. Virology 1998, 245:313-322.
6. Bowie A.G., Haga I.R. The role of Toll-like receptors in the host response to viruses. Mol. Immunol. 2005, 42:859-867.
7. Boyle K.A., Traktman P. Members of a novel family of mammalian protein kinases complement the DNA-negative phenotype of a vaccinia virus ts mutant defective in the B1 kinase. J. Virol. 2004, 78:1992-2005.
8. Bradley C.M., Ronning D.R., Ghirlando R., Craigie R., Dyda F. Structural basis for DNA bridging by barrier-to-autointegration factor. Nat. Struct. Mol. Biol. 2005, 12:935-936.
9. Brown N.G., Nick Morrice D., Beaud G., Hardie G., Leader D.P. Identification of sites phosphorylated by the vaccinia virus B1R kinase in viral protein H5R. BMC Biochem. 2000, 1:2.
10. Broyles S.S., Liu X., Zhu M., Kremer M. Transcription factor YY1 is a vaccinia virus late promoter activator. J. Biol. Chem. 1999, 274:35662-35667.
11. Cai M., Huang Y., Zheng R., Wei S.Q., Ghirlando R., Lee M.S., Craigie R., Gronenborn A.M., Clore G.M. Solution structure of the cellular factor BAF responsible for protecting retroviral DNA from autointegration. Nat. Struct. Biol. 1998, 5:903-909.
12. Challberg M.D., Englund P.T. Purification and properties of the deoxyribonucleic acid polymerase induced by vaccinia virus. J. Biol. Chem. 1979, 254:7812-7819.
13. Condit R.C., Motyczka A., Spizz G. Isolation, characterization, and physical mapping of temperature-sensitive mutants of vaccinia virus. Virology 1983, 128:429-443.
14. Condit R.C., Easterly R., Pacha R.F., Fathi Z., Meis R.J. A Vaccinia virus isatin-β-thiosemicarbazone resistance mutation maps in the viral gene encoding the 132-kDa subunit of RNA polymerase. Virology 1991, 185:857-861.
15. Cox J.L., Mallanna S.K., Ormsbee B.D., Desler M., Wiebe M.S., Rizzino A. Banf1 is required to maintain the self-renewal of both mouse and human embryonic stem cells. J. Cell Sci. 2011, 124:2654-2665.
16. D'Costa S.M., Bainbridge T.W., Condit R.C. Purification and properties of the vaccinia virus mRNA processing factor. J.Biol.Chem. 2008, 283:5267-5275.
17. D'Costa S.M., Bainbridge T.W., Kato S.E., Prins C., Kelley K., Condit R.C. Vaccinia H5 is a multifunctional protein involved in viral DNA replication, postreplicative gene transcription, and virion morphogenesis. Virology 2010, 401:49-60.
18. De Silva F.S., Lewis W., Berglund P., Koonin E.V., Moss B. Poxvirus DNA primase. Proc.Natl.Acad.Sci.USA 2007, 104:18724-18729.
19. De Silva F.S., Paran N., Moss B. Products and substrate/template usage of vaccinia virus DNA primase. Virology 2009, 383:136-141.
20. Dechat T., Gajewski A., Korbei B., Gerlich D., Daigle N., Haraguchi T., Furukawa K., Ellenberg J., Foisner R. LAP2alpha and BAF transiently localize to telomeres and specific regions on chromatin during nuclear assembly. J. Cell. Sci. 2004, 117:6117-6128.
21. Earl P.L., Jones E.V., Moss B. Homology between DNA polymerases of poxviruses, herpesviruses, and adenoviruses: nucleotide sequence of the vaccinia virus DNA polymerase gene. Proc. Natl. Acad. Sci. 1986, 83:3659-3663.
22. Evans E.A., Traktman P. Characterization of vaccinia virus DNA replication mutants with lesions in the D5 gene. Chromosoma 1992, 102:S72-S82.
23. Evans E., Klemperer N., Ghosh R., Traktman P. The vaccinia virus D5 protein, which is required for DNA replication, is a nucleic acid-independent nucleoside triphosphatase. J. Virol. 1995, 69:5353-5361.
24. Fuerst T.R., Niles E.G., Studier F.W., Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc.Natl.Acad.Sci.USA 1986, 83:8122-8126.
25. Furukawa K. LAP2 binding protein 1 (L2BP1/BAF) is a candidate mediator of LAP2-chromatin interaction. J. Cell. Sci. 1999, 112(Pt 15):2485-2492.
26. Furukawa K., Sugiyama S., Osouda S., Goto H., Inagaki M., Horigome T., Omata S., McConnell M., Fisher P.A., Nishida Y. Barrier-to-autointegration factor plays crucial roles in cell cycle progression and nuclear organization in Drosophila. J. Cell Sci. 2003, 116:3811-3823.
27. Haraguchi T., Koujin T., Segura-Totten M., Lee K.K., Matsuoka Y., Yoneda Y., Wilson K.L., Hiraoka Y. BAF is required for emerin assembly into the reforming nuclear envelope. J. Cell Sci. 2001, 114:4575-4585.
28. Harris D., Engelman A. Both the structure and DNA binding function of the barrier-to-autointegration factor contribute to reconstitution of HIV type 1 integration in vitro. J. Biol. Chem. 2000, 275:39671-39677.
29. Ibrahim N., Wicklund A., Wiebe M.S. Molecular characterization of the host defense activity of the barrier to autointegration factor against vaccinia virus. J. Virol. 2011, 85:11588-11600.
30. Katsafanas G.C., Moss B. Vaccinia virus intermediate stage transcription is complemented by Ras-GTPase-activating protein SH3 domain-binding protein (G3BP) and cytoplasmic activation/proliferation-associated Protein (p137) individually or as a heterodimer. J. Biol. Chem. 2004, 279:52210-52217.
31. Keck J.G., Baldick C.J., Moss B. Role of DNA replication in vaccinia virus gene expression: a naked template is required for transcription of three late trans-activator genes. Cell 1990, 61:801-809.
32. Klemperer N., McDonald W., Boyle K., Unger B., Traktman P. The A20R protein is a stoichiometric component of the processive form of vaccinia virus DNA polymerase. J. Virol. 2001, 75:12298-12307.
33. Knutson B.A., Liu X., Oh J., Broyles S.S. Vaccinia virus intermediate and late promoter elements are targeted by the TATA-binding protein. J. Virol. 2006, 80:6784-6793.
34. Knutson B.A., Oh J., Broyles S.S. Downregulation of vaccinia virus intermediate and late promoters by host transcription factor YY1. J. Gen. Virol. 2009, 90:1592-1599.
35. Kovacs G.R., Moss B. The vaccinia virus H5R gene encodes late gene transcription factor 4: purification, cloning, and overexpression. J. Virol. 1996, 70:6796-6802.
36. Kovacs G.R., Vasilakis N., Moss B. Regulation of viral intermediate gene expression by the vaccinia virus B1 protein kinase. J. Virol. 2001, 75:4048-4055.
37. Lee K.K., Haraguchi T., Lee R.S., Koujin T., Hiraoka Y., Wilson K.L. Distinct functional domains in emerin bind lamin A and DNA-bridging protein BAF. J. Cell Sci. 2001, 114:4567-4573.
38. Lee M.S., Craigie R. A previously unidentified host protein protects retroviral DNA from autointegration. Proc. Natl. Acad. Sci. 1998, 95:1528-1533.
39. Lin S., Chen W., Broyles S.S. The vaccinia virus B1R gene product is a serine/threonine protein kinase. J. Virol. 1992, 66:2717-2723.
40. Lucchini S., Rowley G., et al. H-NS mediates the silencing of laterally acquired genes in bacteria. PLoS Pathog. 2006, 2:e81.
41. Margalit A., Neufeld E., Feinstein N., Wilson K.L., Podbilewicz B., Gruenbaum Y. Barrier to autointegration factor blocks premature cell fusion and maintains adult muscle integrity in C. elegans. J. Cell Biol. 2007, 178:661-673.
42. Margalit A., Segura-Totten M., Gruenbaum Y., Wilson K.L. Barrier-to-autointegration factor is required to segregate and enclose chromosomes within the nuclear envelope and assemble the nuclear lamina. Proc.Natl.Acad.Sci.USA 2005, 102:3290-3295.
43. McDonald W.F., Traktman P. Vaccinia virus DNA polymerase. In vitro analysis of parameters affecting processivity. J. Biol. Chem. 1994, 269:31190-31197.
44. McDonald W.F., Klemperer N., Traktman P. Characterization of a processive form of the vaccinia virus DNA polymerase. Virology 1997, 234:168-175.
45. Molitor T.P., Traktman P. Molecular genetic analysis of VRK1 in mammary epithelial cells: depletion slows proliferation in vitro and tumor growth and metastasis in vivo. Oncogenesis 2013, 2:e48.
46. Montes de Oca R., Lee K.K., Wilson K.L. Binding of barrier to autointegration factor (BAF) to histone H3 and selected linker histones including H1.1. J.Biol.Chem. 2005, 280:42252-42262.
47. Montes de Oca R., Shoemaker C.J., Gucek M., Cole R.N., Wilson K.L. Barrier-to-autointegration factor proteome reveals chromatin-regulatory partners. PLoS One 2009, 4:e7050.
48. Moss B., Ahn B.Y., Amegadzie B., Gershon P.D., Keck J.G. Cytoplasmic transcription system encoded by vaccinia virus. J. Biol. Chem. 1991, 266:1355-1358.
49. Moss B., Shisler J.L. Immunology 101 at poxvirus U: immune evasion genes. Semin. Immunol. 2001, 13:59-66.
50. Mostoslavsky R., Chua K.F., Lombard D.B., Pang W.W., Fischer M.R., Gellon L., Liu P., Mostoslavsky G., Franco S., Murphy M.M., Mills K.D., Patel P., Hsu J.T., Hong A.L., Ford E., Cheng H., Kennedy C., Nunez N., Bronson R., Frendewey D., Auerbach W., Valenzuela D., Karow M., Hottiger M.O., Hursting S., Barrett J.C., Guarente L., Mulligan R., Demple B., Yancopoulos G.D., Alt F.W. Genomic Instability and Aging-like Phenotype in the Absence of Mammalian SIRT6. Cell 2006, 124:315-329.
51. Navarre W.W., McClelland M., Libby S.J., Fang F.C. Silencing of xenogeneic DNA by H-NS-facilitation of lateral gene transfer in bacteria by a defense system that recognizes foreign DNA. Genes Dev. 2007, 21:1456-1471.
52. Navarre W.W., Porwollik S., Wang Y., McClelland M., Rosen H., Libby S.J., Fang F.C. Selective silencing of foreign DNA with low GC content by the H-NS protein in Salmonella. Science 2006, 313:236-238.
53. Nezu J., Oku A., Jones M.H., Shimane M. Identification of two novel human putative serine/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus B1R kinase. Genomics 1997, 45:327-331.
54. Nichols R.J., Traktman P. Characterization of three paralogous members of the Mammalian vaccinia related kinase family. J. Biol. Chem. 2004, 279:7934-7946.
55. Nichols R.J., Wiebe M.S., Traktman P. The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in the nucleus. Mol. Biol. Cell 2006, 17:2451-2464.
56. Ory D.S., Neugeboren B.A., Mulligan R.C. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. 1996, 93:11400-11406.
57. Perdiguero B., Esteban M. The interferon system and vaccinia virus evasion mechanisms. J. Interferon Cytokine Res. 2009, 29:581-598.
58. Puente X.S., Quesada V., Osorio F.G., Cabanillas R., Cadinanos J., Fraile J.M., Ordonez G.R., Puente D.A., Gutierrez-Fernandez A., Fanjul-Fernandez M., Levy N., Freije J.M., Lopez-Otin C. Exome sequencing and functional analysis identifies BANF1 mutation as the cause of a hereditary progeroid syndrome. Am. J. Hum. Genet. 2011, 88:650-656.
59. Rempel R.E., Anderson M.K., Evans E., Traktman P. Temperature-sensitive vaccinia virus mutants identify a gene with an essential role in viral replication. J. Virol. 1990, 64:574-583.
60. Rempel R.E., Traktman P. Vaccinia virus B1 kinase: phenotypic analysis of temperature-sensitive mutants and enzymatic characterization of recombinant proteins. J. Virol. 1992, 66:4413-4426.
61. Sanz P., Moss B. Identification of a transcription factor, encoded by two vaccinia virus early genes, that regulates the intermediate stage of viral gene expression. Proc. Natl. Acad. Sci. 1999, 96:2692-2697.
62. Segura-Totten M., Kowalski A.K., Craigie R., Wilson K.L. Barrier-to-autointegration factor: major roles in chromatin decondensation and nuclear assembly. J. Cell Biol. 2002, 158:475-485.
63. Segura-Totten M., Wilson K.L. BAF: roles in chromatin, nuclear structure and retrovirus integration. Trends Cell Biol. 2004, 14:261-266.
64. Shumaker D.K., Lee K.K., Tanhehco Y.C., Craigie R., Wilson K.L. LAP2 binds to BAF.DNA complexes: requirement for the LEM domain and modulation by variable regions. EMBO J. 2001, 20:1754-1764.
65. Skoko D., Li M., Huang Y., Mizuuchi M., Cai M., Bradley C.M., Pease P.J., Xiao B., Marko J.F., Craigie R., Mizuuchi K. Barrier-to-autointegration factor (BAF) condenses DNA by looping. Proc. Natl. Acad. Sci. USA 2009, 106:16610-16615.
66. Sridhar P. and Condit, R.C., 1983. Selection for temperature-sensitive mutations in specific vaccinia virus genes: isolation and characterization of a virus mutant which encodes a phosphonoacetic acid-resistant, temperature-sensitive DNA polymerase. Virology 128, 444-457.
67. Traktman P., Anderson M.K., Rempel R.E. Vaccinia virus encodes an essential gene with strong homology to protein kinases. J. Biol. Chem. 1989, 264:21458-21461.
68. Umland T.C., Wei S.Q., Craigie R., Davies D.R. Structural basis of DNA bridging by barrier-to-autointegration factor. Biochemistry 2000, 39:9130-9138.
69. Valbuena A., Sanz-García M., López-Sánchez I., Vega F.M., Lazo P.A. Roles of VRK1 as a new player in the control of biological processes required for cell division. Cell. Signal 2011, 23:1267-1272.
70. Vos J.C., Stunnenberg H.G. Derepression of a novel class of vaccinia virus genes upon DNA replication. EMBO J. 1988, 7:3487-3492.
71. Wiebe M.S., Traktman P. Poxviral B1 kinase overcomes barrier to autointegration factor, a host defense against virus replication. Cell. Host Microbe. 2007, 1:187-197.
72. Yang Z., Martens C.A., Bruno D.P., Porcella S.F., Moss B. Pervasive initiation and 3'-end formation of poxvirus postreplicative RNAs. J. Biol. Chem. 2012, 287:31050-31060.
73. Zheng R., Ghirlando R., Lee M.S., Mizuuchi K., Krause M., Craigie R. Barrier-to-autointegration factor (BAF) bridges DNA in a discrete, higher-order nucleoprotein complex. Proc. Natl. Acad. Sci. USA 2000, 97:8997-9002.